Sign up to save your podcasts
Or
Share Episode 61: Personalising Anti-VEGF Treatment in Neovascular AMD: Does Phenotype Matter?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Episode 61: Personalising Anti-VEGF Treatment in Neovascular AMD: Does Phenotype Matter?
Dr. Sarah Mrejen (France), Associate Professor Salomon Cohen (France), and Associate Professor Dinah Zur (Israel) explore how neovascular AMD phenotype may influence imaging choices, patient dialogue, and treatment plans. From proactive vs. conservative strategies to new anti-VEGF agents and PCV diagnosis, this expert-led discussion offers key insights into personalising care in retinal disease.
View all episodes
By Whipsmart Media
5
11 ratings
Dr. Sarah Mrejen (France), Associate Professor Salomon Cohen (France), and Associate Professor Dinah Zur (Israel) explore how neovascular AMD phenotype may influence imaging choices, patient dialogue, and treatment plans. From proactive vs. conservative strategies to new anti-VEGF agents and PCV diagnosis, this expert-led discussion offers key insights into personalising care in retinal disease.
More shows like Talking Euretina
View all
Conversations
858 Listeners
Health Report
129 Listeners
New Retina Radio by Eyetube
17 Listeners
The Daily
112,502 Listeners
The Diary Of A CEO with Steven Bartlett
8,500 Listeners
BLICKWINKEL – Der Experten-Talk der Ophthalmologie
0 Listeners
Retina Synthesis
8 Listeners
Headlight in the fog: The Uveitis Podcast
21 Listeners
Pupil Pod
10 Listeners
Experts InSight
51 Listeners
RETINA Journal Podcasts
11 Listeners
Ophthalmology Journal
19 Listeners
Mayo Clinic Ophthalmology Podcast
19 Listeners
Augenblick - Augenheilkunde für die Ohren
0 Listeners
ASRS's History of Retina
0 Listeners